EP3768241
Staðbundin samsetning sem inniheldur kalsípótríól og betametasón díprópíónat
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.3.2019EP published:
8.9.2021EP application number:
19709992.2
EP translation filed:
9.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
17.3.2039Expiry date:
17.3.2027Next due date:
31.3.2027
Title:
TOPICAL COMPOSITION COMPRISING CALCIPOTRIOL AND BETAMETHASONE DIPROPIONATE
Timeline
Today
18.3.2019EP application
8.9.2021EP Publication
9.11.2021Translation submitted
15.12.2021Registration published
17.3.2027Expires
Owner
Name:
MC2 Therapeutics LimitedAddress:
James House Emlyn Lane, Leatherhead Surrey KT22 7EP, GB
Inventor
Name:
CRUTCHLEY, NigelAddress:
Leatherhead Surrey KT22 7EP, GB
Name:
GEORGIOU, MichelleAddress:
Leatherhead Surrey KT22 7EP, GB
Name:
LENON, StephenAddress:
Leatherhead Surrey KT22 7EP, GB
Name:
PRAESTEGAARD, MortenAddress:
Leatherhead Surrey KT22 7EP, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
18162664Date:
19.3.2018Country:
EP
Classification
Categories:
A61K 9/107, A61K 31/593, A61K 31/573, A61K 47/22, A61K 47/10, A61P 17/06
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 8.2.2022
Expires: 17.3.2023
Payer: Árnason Faktor ehf.
Number: 5
Paid: 8.2.2023
Expires: 17.3.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 14.2.2024
Expires: 17.3.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 11.2.2025
Expires: 17.3.2026
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.3.2026
Expires: 17.3.2027
Payer: Árnason Faktor ehf.